Jeremy Grantham United Therapeutics Corp Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$27.2 Billion
Q1 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in United Therapeutics Corp stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 7,236 shares of UTHR stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,236

Holding current value

$2.28 Million

% of portfolio

0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $1.53 Million - $1.81 Million	7,236 New	7,236 $1.66 Million
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $371,950 - $444,371	-2,068 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$170.47 - $211.93 $688,528 - $855,985	-4,039 Reduced 66.14%	2,068 $371,000
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $1.4 Million - $1.59 Million	-9,100 Reduced 59.84%	6,107 $1.02 Million
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $2.52 Million - $3.75 Million	-24,700 Reduced 61.89%	15,207 $2.31 Million

Q3 2020 Nov 13, 2020	BUY	$99.9 - $121.13 $3.4 Million - $4.12 Million	34,007 Added 576.39%	39,907 $4.03 Million
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $222,576 - $301,968	-2,400 Reduced 28.92%	5,900 $714,000
Q1 2020 May 14, 2020	BUY	$79.39 - $115.35 $658,937 - $957,405	8,300 New	8,300 $787,000
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $433,542 - $688,617	-5,700 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$107.15 - $126.84 $53,575 - $63,420	-500 Reduced 8.06%	5,700 $669,000
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $20,228 - $23,662	200 Added 3.33%	6,200 $702,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $385,956 - $546,984	3,600 Added 150.0%	6,000 $674,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,400	2,400 $311,000

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account